Award
National Institute of Neurological Disorders and Stroke 5R01NS120930-05
Molecular basis for adenosine A3 receptor agonists in the treatment of migraine
Recipient
UNIVERSITY OF MARYLAND BALTIMORE
Award Amount
$472,920.00
Ceiling
$472,920.00
Awarded
December 18, 2025
Identifier
5R01NS120930-05
NIH awarded a grant to the University of Maryland Baltimore for research on adenosine A3 receptor agonists as a treatment for migraine, focusing on molecular pharmacology and neuroinflammation.
Description
This is a NIH grant project focusing on migraine research involving molecular pharmacology, neuroinflammation, and receptor signaling. The project aims to validate A3AR as a therapeutic target for migraine treatment.